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The authors found an IE incidence of 0.5% within the first year after TAVI and only a 22.6% incidence of paravalvular extension in the TAVI-IE group. We believe that these rates are probably and largely underestimated because echocardiography has a lower sensitivity to detect the signs of infection of prosthetic valves, especially in the case of TAVI. Recent cases reports and small series support this comment. 2, 3 Indeed, for prosthetic valve IE, ≈30% of periannular abscesses or pseudoaneurysms are not detected by transthoracic and transesophageal echocardiography, resulting in a lower sensitivity of the modified Duke criteria and an inappropriate management. 4 Although the authors reviewed the "possible" diagnoses of TAVI-IE before to include or excluded them from the study, some could be misclassified if echocardiography had been used as the sole imaging technique. Moreover, the limited diagnostic value of echocardiography to detect abscess in this context could explain in part the relatively high incidence of relapses in patients who were not operated on. Thus, TAVI-IE is a new form of endocarditis requiring the description of a new imaging semiology by the use of new techniques such as cardiac computed tomography angiography, 18 F-fluorodeoxyglucosepositron emission tomography/computed tomography, or radiolabeled leucocytes/single-photon emission computed tomography. These techniques have demonstrated their incremental diagnostic value in difficult cases of prosthetic valve IE, and some have proposed the implement of their results into the modified Duke criteria. 4, 5 Did the authors of the present study have any additional data on the imaging techniques used to diagnose the most recent TAVI-IE? For us, the modern diagnostic classification of IE should be adapted to the changing profile of the disease and the emerging imaging techniques.
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